J. Johnston

发表

A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma

D. Gudbjartsson, A. Sigurdsson, A. Jonasdottir, 2017, PLoS genetics.

Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras

J. Johnston, N. Cacalano, D. Sanden, 2001, Nature Cell Biology.

Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase

J. F. Burrows, J. Johnston, M. Gadina, 2007, Journal of Virology.

Structural and functional basis for JAK3-deficient severe combined immunodeficiency.

A. Villa, J. Johnston, L. Notarangelo, 1997, Blood.

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity

J. Johnston, H. Kwok, A. Kissenpfennig, 2011, Molecular Cancer.

Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.

J. Johnston, J. Puck, K. Sugamura, 1996, Blood.

In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction

J. Johnston, L. Notarangelo, J. O’Shea, 1996, The Journal of experimental medicine.

De-ubiquitinating enzymes: intracellular signalling and disease.

J. F. Burrows, J. Johnston, J. Burrows, 2006, Biochemical Society transactions.

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF

J. Johnston, C. Scott, Diana Kuehn, 2010, PloS one.

DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation*

J. F. Burrows, J. Johnston, K. Baek, 2004, Journal of Biological Chemistry.

USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity*

J. F. Burrows, J. Johnston, K. Dib, 2009, Journal of Biological Chemistry.

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.

J. Johnston, A. D’Andrea, D. Sanden, 2001, Blood.

Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens

J. Johnston, J. DeVoss, J. Lesch, 2020, bioRxiv.

proteasomal-mediated turnover CD33 responses are blocked by SOCS3 through accelerated

J. F. Burrows, J. Johnston, Joanne Elliott, 2013 .

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.

J. F. Burrows, J. Johnston, Joanne Elliott, 2007, Blood.

USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptor

J. F. Burrows, J. Johnston, J. Rappoport, 2014, Oncotarget.

Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.

R. Rees, J. Johnston, S. Gupta, 1995, Proceedings of the National Academy of Sciences of the United States of America.

SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases

J. Johnston, S. Constantinescu, A. Green, 2009, Haematologica.

The suppressors of cytokine signalling E3 ligases behave as tumour suppressors.

J. Johnston, Joanne Elliott, Michelle B. Hookham, 2008, Biochemical Society transactions.

SOCS 3 tyrosine phosphorylation as a potential biomarker for myeloproliferative neoplasms associated with mutant JAK 2 kinases

J. Johnston, S. Constantinescu, A. Green, 2022 .

Vasodilator-Stimulated Phosphoprotein Regulates Inside-Out Signaling of β2 Integrins in Neutrophils

J. Johnston, U. Walter, K. Dib, 2010, The Journal of Immunology.

Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation

J. F. Burrows, J. Johnston, D. McAuley, 2015, Science Translational Medicine.

Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas.

J. Johnston, H. Kwok, C. Scott, 2012, Biochimie.

Key Molecules Involved in Receptor‐Mediated Lymphocyte Activation

J. Johnston, J. O’Shea, L. Samelson, 2001, Current protocols in immunology.

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

J. Johnston, O. Silvennoinen, M. Noguchi, 1994, Science.

Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2.

J. Johnston, D. Longo, J. O’Shea, 1995, Blood.

A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells

J. Johnston, O. Witte, D. Woods, 2001, BMC Immunology.

SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated Responses*

J. F. Burrows, J. Johnston, C. Jefferies, 2006, Journal of Biological Chemistry.

A Systematic Interrogation of MHC Class I Peptide Presentation Identifies Constitutive and Compensatory Protein Degradation Pathways

David J. Sherman, Jennifer L Mamrosh, Michael J. Sweredoski, 2021, bioRxiv.

Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*)

D. Taub, J. Johnston, D. Kelvin, 1995, The Journal of Biological Chemistry.

The Deubiquitinating Enzyme USP17 Blocks N-Ras Membrane Trafficking and Activation but Leaves K-Ras Unaffected

J. F. Burrows, J. Johnston, U. Govender, 2010, The Journal of Biological Chemistry.

Genomic sequence, organization, and chromosomal localization of human JAK3.

A. Dutra, J. Johnston, J. O’Shea, 1996, Genomics.

Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

J. Johnston, N. Taylor, W. Paul, 1996, Immunity.

SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses

J. C. Pratt, J. Johnston, A. Kissenpfennig, 2011, The Journal of experimental medicine.

New interleukins: are there any more?

J. Johnston, M. Gadina, Paul Ferguson, 2003, Current opinion in infectious diseases.

Chemokines and serpentines: the molecular biology of chemokine receptors

J. Johnston, D. Kelvin, J. Oppenheim, 1993, Journal of leukocyte biology.

The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.

J. F. Burrows, J. Johnston, J. Burrows, 2005, Genomics.

The DUB / USP 17 deubiquitinating enzymes : A gene family within a tandemly repeated sequence

J. F. Burrows, J. Johnston, J. Burrows, 2010 .

The DUB/USP17 deubiquitinating enzymes: A gene family within a tandemly repeated sequence, is also embedded within the copy number variable Beta-defensin cluster

J. F. Burrows, J. Johnston, J. Burrows, 2010, BMC Genomics.

HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.

Aaron J. Martin, J. Johnston, Jiajia Cui, 2020, Cytotherapy.

Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.

J. Johnston, M. McMahon, D. Chen, 1999, Journal of immunology.

Cell Stability by SOCS2 Inducible Regulatory T + Regulation of Foxp3

J. Johnston, F. Powrie, B. Malissen, 2013 .

A conditionally active form of STAT6 can mimic certain effects of IL-4.

J. Johnston, M. McMahon, H. Lee, 1998, Journal of immunology.

Interleukin-4 Signaling in B Lymphocytes from Patients with X-linked Severe Combined Immunodeficiency*

J. Johnston, N. Taylor, J. Puck, 1997, The Journal of Biological Chemistry.

SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses

J. Johnston, M. Kubo, A. Yoshimura, 2003, Nature Medicine.

Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization

J. Johnston, A. Sica, D. McAuley, 2013 .

Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization.

J. Johnston, A. Sica, D. McAuley, 2013, Immunity.

Are SOCS suppressors, regulators, and degraders?

J. Johnston, 2004, Journal of leukocyte biology.

Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide

J. Johnston, A. Kissenpfennig, P. Fallon, 2014, PloS one.

Abstract 19108: Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Atrial Structure and Function in Chronic Heart Failure (COSMIC-HF)

S. Solomon, J. McMurray, T. Biering-Sørensen, 2016 .

Reconstitution of Btk Signaling by the Atypical Tec Family Tyrosine Kinases Bmx and Txk*

J. Johnston, T. Kurosaki, J. Bolen, 1999, The Journal of Biological Chemistry.

Analysis of Interleukin-2-dependent Signal Transduction through the Shc/Grb2 Adapter Pathway

J. Johnston, M. Goldsmith, W. Greene, 1995, The Journal of Biological Chemistry.

Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.

J. Johnston, J. O’Shea, B. Lal, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.

T. Waldmann, J. Johnston, N. Taylor, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-2 signaling and inherited immunodeficiency.

J. Johnston, N. Cacalano, 1999, American journal of human genetics.

Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide.

D. Taub, J. Johnston, J. Oppenheim, 1994, Journal of immunology.

Regulation of JAK3 expression and activation in human B cells and B cell malignancies.

J. Johnston, D. Longo, J. O’Shea, 1995, Journal of immunology.

Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.

E. Petricoin, R. Rees, J. Johnston, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Cutting Edge: Suppression of GM-CSF Expression in Murine and Human T Cells by IL-27

J. Johnston, C. Hunter, P. Fallon, 2012, The Journal of Immunology.

IL-27Expression in Murine and Human T Cells by Cutting Edge: Suppression of GM-CSF

J. Johnston, C. Hunter, P. Fallon, 2012 .

Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene.

J. Johnston, D. Kelvin, H. Sprenger, 1994, Journal of immunology.

Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor.

J. Johnston, M. Migaud, Richard J Buick, 2011, Journal of immunological methods.

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

J. Johnston, Xuxia Zhang, J. Phillips, 2017, Journal of visualized experiments : JoVE.

IMMUNOGENETICS ’99 Interleukin-2 Signaling and Inherited Immunodeficiency

J. Johnston, N. Cacalano, 1999 .

Matching SOCS with function

J. Johnston, J. O’Shea, 2003, Nature Immunology.

A Novel High-Throughput Technique for Identifying Monoclonal Antibodies Capable of Death Receptor Induced Apoptosis

J. Johnston, H. Kwok, C. Scott, 2009, Journal of cell death.

Brief Definitive Report In Vitro Correction ofJAK3-deficient Severe Combined Immunodeficiency by Retroviral-mediated Gene Transduction

J. Johnston, L. Notarangelo, S. Oakes, 2003 .

order to limit TLR-driven cytokine following lipopolysaccharide stimulation in Siglec-E is up-regulated and phosphorylated

J. Johnston, W. Coulter, C. Jefferies, 2013 .

Siglec-E Is Up-Regulated and Phosphorylated Following Lipopolysaccharide Stimulation in Order to Limit TLR-Driven Cytokine Production1

J. F. Burrows, J. Johnston, W. Coulter, 2009, The Journal of Immunology.

Defects in Acute Rsponses to TLR4 in Btk-deficient Mice Result in Impaired Dendritic Cell-induced IFN-γ Production by Natural Killer Cells

Stacey, J. Johnston, A. Kissenpfennig, 2017 .

Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway.

J. Johnston, R. Badolato, D. Kelvin, 1995, Journal of immunology.

Hepatitis C virus (HCV)‐induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF‐α responses

J. Johnston, N. Stevenson, J. Hegarty, 2014, Journal of leukocyte biology.

Multiplex Immunoassay for Serological Diagnosis of Mycobacterium bovis Infection in Cattle

J. Johnston, H. Kwok, Todd L. Watterson, 2008, Clinical and Vaccine Immunology.

Running Title: Multiplex assay diagnosis of M. bovis infected cattle 3

J. Johnston, Todd L. Watterson, W. Davis, 2008 .

CCL11 blocks IL‐4 and GM‐CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression

J. Johnston, D. Greaves, K. Channon, 2009, Journal of leukocyte biology.

SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation

J. Johnston, G. Tannahill, Joanne Elliott, 2005, Molecular and Cellular Biology.

Hepatitis C virus targets the interferon‐α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes

J. Johnston, M. Binder, A. Long, 2013, FEBS letters.

The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.

J. Johnston, A. Yoshimura, P. Heinrich, 2004, The Biochemical journal.

A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses

J. Johnston, H. Phee, Charles Glaus, 2020, NPJ vaccines.

The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility

J. F. Burrows, J. Johnston, K. Dib, 2011, Nature communications.

Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis

J. Johnston, B. Walker, C. Scott, 2009, Clinical Cancer Research.

Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses

J. Johnston, H. Hsu, Yang Li, 2017, PloS one.

Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2

J. Johnston, J. O’Shea, J. Ortaldo, 1994, Nature.

Cytokine signalling and disease

J. Johnston, L. Hibbert, 2001, Expert opinion on therapeutic targets.

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

J. Johnston, L. Notarangelo, S. Giliani, 1995, Nature.

Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7

J. Johnston, J. O’Shea, L. Varesio, 1995, The Journal of experimental medicine.

Signaling by type I and II cytokine receptors: ten years after.

J. Johnston, D. Hilton, J. O’Shea, 2001, Current opinion in immunology.

Interleukins 2, 4, 7, and 15 Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrates 1 and 2 in T Cells POTENTIAL ROLE OF JAK KINASES (*)

J. Johnston, M. White, J. O’Shea, 1995, The Journal of Biological Chemistry.

J. Johnston, W. Paul, J. O’Shea, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The deubiquitinating enzyme USP17 is associated with nonsmall cell lung cancer (NSCLC) recurrence and metastasis

J. Johnston, K. Kerr, D. Fennell, 2013, Oncotarget.

Advances in the Understanding of Cytokine Signal Transduction: The Role of Jaks and STATs in Immunoregulation and the Pathogenesis of Immunodeficiency

J. Johnston, L. Notarangelo, J. O’Shea, 1997, Journal of Clinical Immunology.

Autosomal SCID caused by a point mutation in the N‐terminus of Jak3: mapping of the Jak3–receptor interaction domain

J. Johnston, F. Bazan, J. O’Shea, 1999, The EMBO journal.

Signaling by IL‐2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency

J. Johnston, J. O’Shea, C. Bacon, 1996, Journal of leukocyte biology.

Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12

R. Rees, J. Johnston, J. O’Shea, 1995, The Journal of experimental medicine.

Regulation of CD4+ T‐cell polarization by suppressor of cytokine signalling proteins

J. Johnston, Camille A. Knosp, 2012, Immunology.

Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain

J. Johnston, A. Yoshimura, A. Suzuki, 1999, Genes to cells : devoted to molecular & cellular mechanisms.

Machinery and Transactivation by Stat5 Recruitment of the Basal Transcription Deacetylase Activity Is Required For

J. Johnston, B. Amati, A. Rascle, 2022 .

The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.

J. F. Burrows, J. Johnston, U. Govender, 2010, Cancer research.

Tumor and Stem Cell Biology Cancer Research The Deubiquitinating Enzyme USP 17 Is Highly Expressed in Tumor Biopsies , Is Cell Cycle Regulated , and Is Required for G 1S Progression

J. F. Burrows, J. Johnston, U. Govender, 2010 .

Regulation of Foxp3+ Inducible Regulatory T Cell Stability by SOCS2

J. Johnston, F. Powrie, B. Malissen, 2013, The Journal of Immunology.

Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma.

J. Johnston, P. Steinlein, T. Decker, 1999, Journal of immunology.

Substitution of Pseudokinase Domain Residue Val-617 by Large Non-polar Amino Acids Causes Activation of JAK2*

Stefan N Constantinescu, Joanne Elliott, J. Johnston, 2008, Journal of Biological Chemistry.

SOCS-3 Is Tyrosine Phosphorylated in Response to Interleukin-2 and Suppresses STAT5 Phosphorylation and Lymphocyte Proliferation

J. Johnston, A. Yoshimura, A. Mui, 1999, Molecular and Cellular Biology.

Cathepsin S from both tumor and tumor‐associated cells promote cancer growth and neovascularization

J. F. Burrows, J. Johnston, A. Kissenpfennig, 2013, International journal of cancer.

Cathepsin S from both tumour and tumour-associated cells promote cancer growth

Cheryl, J. Johnston, H. McCarthy, 2013 .

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study

J. Johnston, E. Kay, P. Johnston, 2011, British Journal of Cancer.

Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L–like proteases in tumor microenvironment

J. Johnston, B. Walker, Richard J Buick, 2008, Molecular Cancer Therapeutics.

Suppressor of Cytokine Signaling-3 Is Recruited to the Activated Granulocyte-Colony Stimulating Factor Receptor and Modulates its Signal Transduction1

J. Johnston, P. Heinrich, S. Haan, 2002, The Journal of Immunology.

A new polycythaemia vera‐associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses

J. Johnston, M. McMullin, C. Harrison, 2009, British Journal of Haematology.

The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.

Mary Frances McMullin, Stefan N Constantinescu, Melanie J Percy, 2007, Blood.

The Chemoattractants, IL-8 and Formyl-Methionyl-Leucyl-Phenylalanine, Regulate Granulocyte Colony-Stimulating Factor Signaling by Inducing Suppressor of Cytokine Signaling-1 Expression1

J. Johnston, P. Heinrich, S. Haan, 2004, The Journal of Immunology.

Staurosporine restores signaling and inhibits interleukin‐8‐induced chemotactic desensitization

J. Johnston, D. Longo, D. Ferris, 1994, European journal of immunology.

Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation*

J. Johnston, P. Heinrich, S. Haan, 2003, Journal of Biological Chemistry.

SOCS: role in inflammation, allergy and homeostasis.

J. Johnston, Joanne Elliott, 2004, Trends in immunology.

Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation

J. Johnston, P. Heinrich, S. Haan, 2005, Journal of Biological Chemistry.

A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production

J. Johnston, M. Kubo, A. Yoshimura, 2003, The Journal of experimental medicine.

Regulation of cellular responses by deubiquitinating enzymes: an update.

J. F. Burrows, J. Johnston, 2012, Frontiers in bioscience.

Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma

J. Johnston, P. Bradding, A. Kissenpfennig, 2016, European Respiratory Journal.

Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11

J. Johnston, D. Greaves, A. Long, 2010, FEBS letters.

Ubiquitination: Added complexity in Ras and Rho family GTPase function.

J. F. Burrows, J. Johnston, Michelle de la Vega, 2011, Small GTPases.

Ubiquitination

J. F. Burrows, J. Johnston, M. de la Vega, 2011, Co and Post-Translational Modifications of Therapeutic Antibodies and Proteins.

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Dirk E. Smith, J. Johnston, O. Homann, 2018, bioRxiv.

Expression and purification of diagnostically sensitive mycobacterial (Mycobacterium bovis) antigens and profiling of their humoral immune response in a rabbit model.

J. Johnston, H. Kwok, Richard J Buick, 2010, Research in veterinary science.

Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation

David J. Sherman, Jennifer L Mamrosh, Michael J. Sweredoski, 2023, Science advances.

IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation

J. Johnston, G. Ogg, A. McKenzie, 2017, The Journal of Immunology.

Interleukin-17 receptor A maintains and protects the skin barrier to prevent allergic skin inflammation 1

J. Johnston, G. Ogg, A. McKenzie, 2017 .

This information is current as Inflammation Skin Barrier To Prevent Allergic Skin IL-17 Receptor A Maintains and Protects the Walsh and

J. Johnston, G. Ogg, A. McKenzie, 2017 .

A novel RCE1 isoform is required for H-Ras plasma membrane localization and is regulated by USP17.

J. F. Burrows, J. Johnston, N. Rawlings, 2014, The Biochemical journal.

USP17-like Peptidase/DUB3 Peptidase

J. F. Burrows, J. Johnston, C. Scott, 2013 .

Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization.

J. Johnston, A. Sica, D. McAuley, 2013, Immunity.

Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5

J. Johnston, B. Amati, A. Rascle, 2003, Molecular and Cellular Biology.

Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production

J. F. Burrows, J. Johnston, W. Coulter, 2010, The Journal of Immunology.

Interleukin-4 Signaling in B Lymphocytes from Patients with X-linked Severe Combined Immunodeficiency*

J. Johnston, N. Taylor, J. Puck, 1997, The Journal of Biological Chemistry.

Tyrosine Phosphorylation and Activation of Stat5, Stat3, and Janus Kinases by Interleukin-2 and Interleukin-15

R. Rees, J. Johnston, J. O’Shea, 1995 .